Aims There is evidence to suggest that stromal interaction molecule 1 (STIM1) functions as a Ca 2þ sensor on the endoplasmic reticulum, leading to transduction of signals to the plasma membrane and opening of store-operated Ca 2þ channels (SOC). SOC have been detected in vascular smooth muscle cells (VSMCs) and are thought to have an essential role in the regulation of contraction and cell proliferation. We hypothesized that knockdown of STIM1 inhibits VSMC proliferation and suppresses neointimal hyperplasia.
Introduction
The atherosclerotic process is characterized by the recruitment of monocytes and lymphocytes to the arterial intima. The subsequent accumulation and proliferation of vascular smooth muscle cells (VSMCs), which immigrate from the medial layer, lead to lesion progression and encroachment on the coronary vascular lumen. 1 Despite the fact that the use of percutaneous coronary intervention (PCI) has improved the results of atherosclerosis significantly, understanding restenosis after PCI remains a challenge. Restenosis refers to the re-occurrence of stenosis on the basis of intimal lesion, and the major contribution to this process is the proliferation and migration of medial VSMCs. 2 Therefore, proliferation of VSMCs is a key event in atherosclerosis and restenosis after vascular injury; however, the underlying mechanism of VSMCs' proliferation is unclear.
Ca 2þ channels are of particular interest in cell proliferation because of the profound anti-proliferative effect of removing extracellular Ca 2þ and evidence from studies of many cell types that Ca 2þ entry mechanisms have an essential role. 3, 4 Elevation of Ca 2þ levels in VSMCs can result from entry of extracellular Ca 2þ as well as release of Ca 2þ sequestered within organelles such as the sarcoplasmic reticulum (SR). Ca 2þ influx across the plasma membrane (PM) is mediated by voltage-dependent Ca 2þ channels, and voltage-independent cation channels, including storeoperated Ca 2þ channels (SOC). 5, 6 It has been recognized that phenotypic modulation of VSMCs is associated with downregulation of voltage-dependent Ca 2þ channels, which provide Ca 2þ entry for contraction when the cells are in the contractile phenotype of the physiological blood vessel and are the target of antihypertensive calcium antagonist drugs. 6 What are the Ca 2þ channels of the proliferating VSMCs? Store-operated Ca 2þ entry (SOCE), also known as capacitative Ca 2þ entry, is thought to have an essential role in the regulation of contraction, cell proliferation, and apoptosis. [7] [8] [9] Meanwhile, it has been reported that SOCE has been detected in VSMCs. 10 The activation of SOCE is triggered by a reduction in the concentration of SR Ca 2þ . Transient discharge of SR Ca 2þ † R-W.G. and H.W. contributed equally to this work.
occurs during the course of signalling events that activate inositol 1,4,5-trisphosphate receptors or ryanodine receptors in the SR membrane. SR Ca 2þ stores can be depleted by inhibiting sarcoendoplasmic reticulum Ca 2þ ATPases with thapsigargin (TG). 11 Although several biophysically distinct SOCE have been reported, the best characterized are the Ca 2þ release-activated Ca 2þ (CRAC) channels. Over the years, many genes have been claimed to code for the CRAC channel. Recently, an RNAi-based screening approach revealed a novel membrane-spanning protein named stromal interaction molecule 1 (STIM1) to be required for the activation of SOCE.
12 STIM1 is dispersed on the endoplasmic reticulum (ER) membrane under quiescence. Ca 2þ store depletion stimulates redistribution of STIM1 to the PM. The redistribution is thought to transmit a store depletion signal to the CRAC channels in the PM. Evidence indicates that STIM1 may function as a Ca 2þ sensor in the ER, leading to transduction of this signal to the PM and opening of SOC located in the PM. 12, 13 Nevertheless, there has been relatively little association of STIM1 with human disease, little direct evidence that STIM1 knockdown could be an effective therapeutic strategy, and no link between STIM1 and organ function. We have focused on the suggestion that STIM1 might have a role in vascular disease. Here, we present evidence from in vivo and in vitro studies that STIM1 does have an essential role in the proliferation of VSMCs, and we consider the relevance to the adaptive injury response of blood vessels.
Methods

Reagents
The one-step RT-PCR kit was from TaKaRa (Shiga, Japan). The anti-STIM1 antibody (25-139) was purchased from BD (NJ, USA); anti-PCNA were from Santa Cruz (CA, USA); and anti-smooth muscle a-actin (SMaA) antibody were from NeoMarkers (CA, USA); anti-pRb, anti-p21, and anti-b-actin antibody were from Sigma (MO, USA). Fetal bovine serum (FBS) was obtained from HyClone (UT, USA). Medium and supplements were purchased from Gibco BRL (NY, USA). Fura-2AM was obtained from Beyotime Chemical Company (Jiangshu, China). TG was from Sigma (MO, USA).
Construction of adenoviral vectors
All small interfering RNA (siRNA) sequences were designed as described.
14 A mixture of two siRNA duplex sequences exclusively targeting rat STIM1 (rSTIM1, GenBank accession number NM_001108496), but not human STIM1 (hSTIM1, GenBank accession number U52426) were used. (i) Start nucleotide 935, GCAUGGAAGG-CAUCAGAAGUGUAUA; and (ii) start nucleotide 970, GGAUGAGGU-GAUACAGUGGCUGAUU. A non-silencing control (NSC) sequence was designed according to the sequence of a negative control. Target sequences for rSTIM1 were chemically synthesized (Genesil, China) as complementary oligonucleotides. Annealed oligonucleotides encoding sense and antisense strands linked by the loop sequence were subcloned into pGS-1 (Genesil, China). hSTIM1 DNA expression constructs were as described.
14 The 2.7 kb fragment of hSTIM1 was subcloned into pGS-1 either as a wild-type cDNA fragment or after introduction of a premature stop codon (PEST), producing a 597 amino acid residue PEST protein without the two proline-rich regions (residues 617-634 and 651-671). Recombinant viral genomes were transfected into 293 cells in a 6-well plate using METAFECTENE TM (Biontex). Eight days after transfection, the recombinant virus was collected and subjected to one round of amplification in a T-75 flask with 1.5 Â 10 6 293 cells, resulting in 2 mL of viral stock. The Ad-si/rSTIM1 and Ad-hSTIM1 viruses were titrated using the standard plaque assay. The titre for Ad-si/STIM1 was 3 Â 10 9 plaque-forming units (pfu)/mL. All adenoviruses expressed GFP under a separate promoter, allowing verification of infection. An NSC sequence was generated in the same manner.
Balloon angioplasty and delivery of adenoviruses
Male Wistar rats weighing 250-300 g (Chongqing, China) were anaesthetized with an intramuscular injection of 100 mg/kg ketamine and 5 mg/kg xylazine. Angioplasty of the left carotid artery was performed by using a balloon embolectomy catheter (1.5F, Cordis; USA) as described. 15 The balloon catheter was introduced through the left external carotid artery into the common carotid artery and inflated at 2 atm with a calibrated inflation device. The carotid artery was damaged by passing the inflated balloon catheter back and forth through the lumen three times. Some animals were subjected to anaesthesia and surgical procedure without balloon injury (sham-operated rats). After balloon injury, solutions of (20 mL) Ad-si/rSTIM1 (3 Â 10 9 pfu/mL), Ad-hSTIM1 (3 Â 10 9 pfu/mL), or NSC (3 Â 10 9 pfu/mL) were infused into the ligated segment of the common carotid artery for 20 min. The ligatures and catheter were then removed, the external carotid artery was ligated, and the incision was closed. At 7 days and 14 days after arteriotomy, rats were anaesthetized and carotid arteries were carefully dissected free from surrounding tissue and perfused at physiological pressure with 4% paraformaldehyde in PBS for fixation. The balloon injury model used is purely one of proliferation. All studies conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85-23, revised 1996).
Cell culture and adenoviral transduction
Rat aortic VSMCs were isolated and subcultured as described. 16 VSMCs between three and seven passages were quiesced by incubating in serum-free DMEM for 24 h at 378C and used for the in vitro experiments unless stated otherwise. VSMCs were transduced with Ad-si/rSTIM1, Ad-hSTIM1, or NSC, and STIM1 protein levels were evaluated in the cell extracts.
Morphology
Morphometry was performed as described. 17 Briefly, at 7 and 14 days after angioplasty, animals were anaesthetized as described above, and the carotid arteries were fixed by perfusion with 100 mL of PBS (pH 7.2), followed by 80 mL of PBS containing 4% paraformaldehyde through a large cannula placed in the left ventricle. The carotid arteries were removed, and six cross-sections were cut from the approximate middle of the artery. The sections were stained with haematoxylin and eosin to demarcate cell types and were photographed under low power, video-digitized, and stored in an image analysis system. The media, neointima, and vessel walls were traced carefully, and the neointima and media area was calculated. To investigate the lumen loss of each group, the lumen area of injured carotid (LAi) was measured and normalized by the arterial area measure of the contralateral non-injured carotid (LAc) of the same animal. The lumen loss ratio was calculated as: lumen loss ratio ¼ (Lac 2 LAi)/LacÂ100%.
Western blotting
The injured vessels without adventitia or VSMC protein were extracted as described. 16 Equal amounts of protein were separated by SDS-PAGE (10% polyacrylamide gel). The protein was subsequently transferred onto a polyvinylidene difluoride membrane by electroblotting for 3 h at 150 mA. The membrane was blocked in a 5% non-fat milk solution in TBS with 0.5% Tween 20. The membrane was allowed to react with primary antibody and detection of specific proteins was done by enhanced chemiluminescence following the manufacturer's instructions. Densitometric signals were quantified by Quantity One.
Transwell migration assay
The effect of STIM1 knockdown on VSMCs migration was determined by a transwell migration assay as described. 18 Briefly, VSMCs were transfected with adenovirus expressing NSC, siRNAs against rSTIM1, and siRNAs against rSTIM1 plus hSTIM1. At 48 h after transfection, VSMCs (25 000 cells/chamber) were plated onto the upper chamber of Transwell (Costar) inserts with 8 mm pore size (BD-Biosciences). Chemotaxis was achieved by the presence of 5% serum in the chamber bottom. After 4 h, the transwell chambers were rinsed in PBS, and cells on top of the chamber were removed with a cotton swab. Cells on the bottom of the Transwell membrane were fixed with 4% paraformaldehyde at 378C for 15 min, and then rinsed with PBS. To quantify the number of migrating cells on the bottom of the Transwell, cells were labelled with DAPI, and then cells that had migrated were counted manually using a fluorescent microscope. In all cases, five separate highpower fields were counted per membrane.
RNA isolation and real-time RT-PCR
Total RNA was isolated with TRIzol w reagent according to the manufacturer's protocol. 19 Total RNA was reverse-transcribed into cDNA, and the resultant cDNA was amplified by SYBR Green1 fluorescence real-time RT-PCR. The PCR reaction was directly monitored by the Bioer FQD-66A sequence detection system. The primers for rSTIM1 were 
Cell-cycle analysis and cell counting
Cell-cycle distribution was analysed using flow cytometry. Briefly, VSMCs were trypsinized, washed with PBS, and fixed in 80% ethanol. They were then washed with PBS, incubated with 100 mg/mL RNase at 378C for 30 min, stained with propidium iodide (50 mg/mL), and analysed on an FACScan flow cytometer. The percentage of cells in different phases of the cell cycle was determined using the Cell-FIT software. The growth curves of VSMCs were examined using cell counting. Cells first underwent mitogenic quiescence by serum starvation and viral infection. The cell number under these experimental conditions was used as the baseline. To examine the status of VSMC proliferation, the cells were subsequently stimulated with serum (10% FBS), and the cell number was counted every day for 3 days. Each count was an average of three repeats, and each datum point was the average of three experiments.
Double-immunofluorescence staining
Carotid arteries were snap-frozen in liquid nitrogen in OCT embedding medium and stored at 2808C. Six cross-sections were cut (6 mm) from the approximate middle portion of the artery and used for STIM1 and SMaA detection by immunofluorescence. 20 For staining, sections were fixed in acetone for 10 min, air dried, and rehydrated with PBS before incubation in serum-free protein block for 30 min. To detect STIM1, sections were stained with anti-rat STIM1 antibody (mouse IgG) diluted in 1% blocking reagent/0.3% Triton X-100 in PBS overnight before being washed in TNT wash buffer (Tris-HCl, pH 7.5, 0.15 mol/L NaCl, and 0.05% Tween 20, Sigma). Sections incubated with an isotype-matched control antibody were used as negative control. Subsequently, sections were incubated with TRITC-goat anti-mouse IgG for 30 min before washing. Anti-rat SMaA (rabbit IgG) and FITC-goat anti-rabbit IgG were used for detecting SMaA as described above. Images were taken by a confocal laser scanning microscope (Leica TCS SP5, Germany).
Measurement of intracellular free Ca 21 , [Ca 21 ]i
The VSMCs were loaded with the calcium indicator Fura-2AM (5 mM) in Hepes-buffered saline. Changes in [Ca 2þ ]i in individual cells were measured using an Aquacosmos system with band-pass filters for 340 and 380 nm. [Ca 2þ ]i was calculated from the Fura-2 fluorescence ratio (F340/F380) using linear regression between adjacent points on a calibration curve generated by measuring F340/F380 in at least seven calibration solutions containing Ca 2þ at concentrations between 0 and 854 nM. The SOC-mediated influx of Ca 2þ following stimulation with 1 mM TG during the change from Ca 2þ -free conditions to 2 mM Ca 2þ was measured as described. 
Statistical analysis
Results are expressed as mean+SEM of n rats for in vivo experiments and mean+SEM of multiple experiments for molecular biology. SPSS13.0 software was used for statistical analysis. Student's t-tests were used to compare the two groups, or ANOVA was used with Tukey's multiple comparison tests for multiple groups. Values of P , 0.05 were regarded as statistically significant.
Results
Expression of STIM1 in rat carotid arteries after balloon angioplasty
To determine whether STIM1 mRNA and protein were expressed in rat carotid arteries after balloon angioplasty, real-time RT-PCR and western blotting were done with total RNA and cytosolic protein extracts from carotid arteries. STIM1 mRNA and protein were detected in carotid arteries subjected to vascular injury, whereas their expression was low in uninjured right carotid arteries at 7 and 14 days after balloon angioplasty ( Figure 1A and B) . Meanwhile, when compared with the sham groups, STIM1 mRNA and protein in the left injured carotid had increased significantly at 7 days after balloon angioplasty and further increased at 14 days after balloon angioplasty. We conclude from these observations that the expression of STIM1 was upregulated after balloon angioplasty.
Localization of STIM1 and SMaA in rat carotid arteries
Localization of STIM1 and SMaA-positive cells in rat carotid arteries was done by double-immunofluorescence staining to determine the spatial distribution and cellular localization of STIM1. A clear immunoreactivity for STIM1 and SMaA was detected in the media at 7 days and 14 days after balloon angioplasty (Figure 2 ). In addition, immunoreactivity for STIM1 and SMaA was observed mostly in neointima at days 7 and 14. These results suggest that STIM1 is expressed in proliferating SMCs, contributing greatly to neointimal formation.
STIM1 silencing attenuates neointima formation in vivo
We first examined the efficiency of adenovirus transfection in rat carotid arteries by western blot analysis. The level of GFP expression reached a maximum at day 3 and remained high until days 7 and 14 after adenoviral infection. These results suggest that the adenovirus-mediated delivery system was effective in rat carotid artery (see Supplementary material online, Figure S1 ). We delivered adenovirus constructs expressing NSC, Ad-hSTIM1, and Ad-si/rSTIM1 to rat carotid arteries. Expression of STIM1 protein (without adventitia) was confirmed by western blotting. Compared with the NSC group, incubation with Ad-si/rSTIM1 attenuated injury-induced STIM1 upregulation significantly. Cotransfection with Ad-hSTIM1 reversed the downregulation of STIM1 by RNAi ( Figure 3A) . Interestingly, the neointimal formation area and lumen loss ratio at day 14 were reduced significantly by transfection with Ad-si/rSTIM1 compared with transfection with NSC. When Ad-hSTIM1 was transfected with Ad-si/rSTIM1, the neointimal formation area and lumen loss ratio were restored to near the control level ( Figure 3B and C, Supplementary material online, Figure S2 ). These results indicated that inhibition of STIM1 could reduce neointimal hyperplasia in vivo. Concomitantly, the expression of PCNA in rat carotid arteries at 14 days after injury was much lower in the Ad-si/rSTIM1-treated group than in the NSC group. The transfection of Ad-hSTIM1 with Ad-si/rSTIM1 restored the expression of PCNA in rat carotid arteries to near the level of that in the NSC group. In addition, STIM1 knockdown caused an increase in the expression of p21, and a significant reduction in the phosphorylation of Rb (pRb) in vivo at 14 days after injury. No significantly differences were found between the sham group and the Ad-si/rSTIM1-treated group on the expression of PCNA, p21, and pRb ( Figure 3D ).
Suppression of STIM1 inhibits VSMCs proliferation and migration in vitro
The VSMCs are the primary cell type transduced by adenovirus in the rat balloon injury model and the major cell type contributing to neointimal hyperplasia after balloon injury. To determine whether endogenous STIM1 had an effect on VSMC proliferation, rat aortic VSMCs were cultured for use in in vitro experiments. Adenovirus constructs expressing NSC, hSTIM1, and si/rSTIM1 were added to rat aortic VSMCs. The transfection efficiency of adenovirus GFP expression in cultured VSMCs was 92.4 + 7.6% (see Supplementary material online, Figure S3 ). The basal and induced STIM1 levels were detected in vitro by immunoblotting. In addition, the effects of STIM1 silencing in nonstimulated and stimulated VSMCs also were demonstrated at 48 h post-transduction (see Supplementary material online, Figure S4 ). Transduction of VSMCs with Ad-si/ rSTIM1 (MOI 15 and 30 pfu/cell) effectively decreased STIM1 protein expression at 48 h post-transduction. The cotransfection of Ad-hSTIM1 (MOI 15 pfu/cell) with Ad-si/ rSTIM1 (MOI 15 pfu/cell) restored the expression of STIM1 protein ( Figure 4A) . Interestingly, transfection of VSMCs with Ad-si/rSTIM1 decreased the uptake of [ 3 H]thymidine by VSMCs significantly at 48 h after infection. The cotransfection of Ad-hSTIM1 reversed the effect of STIM1 knockdown on [ 3 H]thymidine uptake ( Figure 4B) . Concomitantly, transfection of VSMCs with Ad-si/rSTIM1 suppressed proliferation of VSMCs significantly (MOI 15 pfu/cell), and hSTIM1 re-expression reversed the effect of STIM1 knockdown on VSMC proliferation ( Figure 4C ). These results demonstrated that knockdown of STIM1 could suppress VSMC proliferation in vitro.
Transwell assays were used to assess the effects of STIM1 knockdown on migrated cells. Transfection of VSMCs with Ad-si/rSTIM1 decreased the number of migrating cells significantly at 48 h after infection. In this rSTIM1 knockdown background, hSTIM1 re-expression reversed the effect of STIM1 knockdown on a number of migrating cells ( Figure 4D ). In addition, we evaluated the effect of siRNA targeted against rSTIM1 on SOCE, which was activated by the depletion of intracellular Ca 2þ stores using 1 mM TG in the absence of extracellular Ca 2þ , followed by the addition of extracellular Ca 2þ to 2 mM. The TG-mediated SOCE may be attributed to the release of Ca 2þ from the SR. The infection of Ad-si/rSTIM1 (MOI 15 pfu/cell at 48 h after infection) resulted in a marked decrease in SOCE. However, the cotransfection of cells with Ad-hSTIM1 (MOI 15 pfu/cell) reversed the effect of STIM1 knockdown on intracellular Ca 2þ of VSMCs ( Figure 4E ). These results demonstrated that SOCE influx may have a key role in VSMC proliferation.
The role of STIM1 in regulating the VSMC cell cycle
We used flow cytometry to examine the possible alteration of the cell cycle in response to STIM1 knockdown. Cultured VSMCs were first synchronized and stimulated with serum to initiate cell-cycle progression, and then infected with NSC, Ad-hSTIM1, and Ad-si/rSTIM1 for 48 h. Fluorescenceactivated cell sorting was used to examine cell-cycle distribution ( Figure 5A ). Approximately 13% of VSMCs infected by NSC (MOI 30 pfu/cell) or 16% of uninfected VMSCs progressed into the S phase. VSMCs infected by Ad-si/rSTIM1 (MOI 30 pfu/cell) were distributed mainly in the G0/G1 phase, and only 1.6% of cells progressed into the S phase. After VSMCs were transfected with Ad-hSTIM1 (MOI 15 pfu/cell), 16% of cells progressed into the S phase ( Figure 5B ). The effect of STIM1 knockdown on cell-cycle arrest was also manifest by alterations in key components of the cell-cycle regulatory machinery. STIM1 knockdown caused an increase in the expression of the CDK inhibitor p21 and a significant reduction in the phosphorylation of Rb(pRb), thus permitting the accumulation of the hypo-phosphorylated, growthsuppressive form of Rb ( Figure 5C ).
Discussion
The present results identify a critical role for STIM1 in neointimal formation in a rat model of vascular injury and suggest a potential role for STIM1 knockdown in the reduction of neointimal development. Meanwhile, we have demonstrated that STIM1 is a powerful regulator of cell proliferation both in vivo and in vitro. This conclusion is based on several independent lines of evidence. First, an overt upregulation of STIM1 expression in vivo was associated with balloon injury-induced VSMC hyper-proliferation in rat carotid arteries. Secondly, knockdown of endogenous STIM1 by adenoviral delivery of siRNA significantly suppressed neointimal hyperplasia in vivo, which was reversed by STIM1 replenishment. Thirdly, STIM1 knockdown inhibited SOCE in cultured VSMCs and blocked serum-induced VSMCs proliferation in vitro, which was also reversed by STIM1 replenishment. In addition, suppression of STIM1 also inhibits VSMCs migration in vitro. These observations suggest that expression and function of STIM1 after vascular injury may contribute to neointimal formation.
It is clear that increased Ca 2þ influx is an important stimulus for SMC proliferation. Recently, it has been reported that transient receptor potential (TRP) channel genes encode Ca 2þ channels that are responsible for Ca 2þ entry during smooth muscle cell proliferation. 10, 23 TRP was found first in Drosophila and has an essential role in the visual response of the fly. 24 Several homologues of the TRP channel family, such as TRPC1 and TRPC6, are expressed in mammalian cells and have intriguing sensing capabilities for a range of factors, including redox status and growth factors. 23, 25, 26 Yu et al. 27 reported that inhibition of TRPC6 expression with TRPC6 siRNA markedly attenuated the proliferation of pulmonary artery smooth muscle cells. Kumar et al. 23 reported that a specific E3-targeted antibody to TRPC1 and the chemical blocker 2-aminoethoxydiphenyl borate significantly reduced neointimal growth in human veins, as well as Ca 2þ entry and proliferation of smooth muscle cells in culture. There is evidence that TRP channel genes encode subunits that form SOC channels in many cell types, including SMC. 28, 32 Ca 2þ entry through SOC increases intracellular Ca 2þ , allowing for phosphorylation of signal transduction proteins and transcription factors, which are essential for the progression of the cell cycle. 29, 30 Other major functions of the SOCE pathway are believed to be maintenance of SR Ca 2þ levels, which are required for VSMC proliferation. 31 Activation of SOCE is triggered by a reduction in SR Ca 2þ concentration. More recently, an RNAi-based screening approach revealed the novel membrane-spanning protein STIM1 to be required for the activation of SOC. 12 STIM1 is dispersed on the ER membrane in quiescence, and Ca 2þ store depletion stimulates redistribution of STIM1 to the PM. The redistribution is thought to transmit a store depletion signal to the SOC in the PM. 32 In the present study, we demonstrated that direct inhibition of STIM1 can attenuate an SOC-mediated increase of intracellular Ca 2þ and suppress VSMCs proliferation, which reduced neointimal development. Takahashi and Lu have reported that STIM1 knockdown can suppress VSMCs proliferation in vitro.
33,34
Spassova et al.
14 showed that re-expression of hSTIM1 in rat basophilic lymphoma cells of rSTIM1 knockdown could restore the activity of SOC. Our data indicated that re-expression of hSTIM1 in VSMCs reversed the effect of STIM1 knockdown on intracellular Ca 2þ , cell proliferation, and neointimal development.
In addition, we have demonstrated that STIM1 knockdowninduced suppression of VSMC proliferation is associated with an increase in the expression of the CDK inhibitor p21. Meanwhile, STIM1 knockdown attenuates phosphorylation of Rb, resulting in the accumulation of hypophosphorylated Rb in cultured VSMCs; Rb is one of the major modulators of the G1/S transition in mammalian cells. When hypo-phosphorylated in G0/G1, Rb blocks cellcycle progression by binding to and suppressing the activities of transcription factors such as E2F family members. 35, 36 Consistent with this, the increase in growth-suppressive, hypo-phosphorylated Rb contributes, at least in part, to STIM1 knockdown-induced cell-cycle arrest in G0/G1.
In summary, we show that STIM1 is a critical regulator of VSMC proliferation and neointimal hyperplasia. STIM1 may represent a novel therapeutic target in the prevention of restenosis after vascular intervention.
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